ClinicalTrials.gg
Active, not recruitingNCT07632183Updated Jun 8, 2026

Will a Hands on Technique Applied to the Face Increase the Tear Production in Participants

An interventional study of sphenopalatine ganglion release in Increased Production of Tears, sponsored by Edward Via Virginia College of Osteopathic Medicine. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by Edward Via Virginia College of Osteopathic Medicine · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Oct 2024, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The goal of this interventional study is to learn if a hands on technique will increase tear production in patients aged 45 and younger, without a history of eye issues. The main question it aims to answer is:

Will there be an increase in tear production using a specific hand on technique applied inside the mouth?

Participants will have a small, sterile, piece of paper that will be placed briefly in their eye. This is done to take measurements of tear production. A doctor will then perform a hands on technique in which a gloved finger is placed in the participants' mouth to release the tension that is found. After the technique is completed, the participants' eye will be retested with the tear strip. The tear test strip will be applied twice more on the following visits at 2 days after the first session and one week after the first session

Read the detailed description

This study is designed as an experimental pilot study for proof of concept with pre- and post- test measurements taken on the same individual. We will be measuring at time points 0 (baseline), immediately after treatment (within 5 minutes), 2 day, and 1 week each with a standardized Schirmer's Test for tear production. This study is intended to gather data on around 30 individuals within the set inclusion/exclusion criteria.

The proposed mechanism is that stimulation of the parasympathetic nervous system via the sphenopalatine ganglion may induce increased lacrimation and provide relief (of yet unknown duration or efficacy) for patients who report sensations of dry eye

02

Conditions studied

  • Increased Production of Tears

Browse trials for

Keywords

  • Osteopathic Manipulative Medicine
  • Osteopathic Manipulative Technique
  • tear production
  • sphenopalatine ganglion
  • sphenopalatine ganglion release
03

In context

Lacerations

174 studies on the registry are indexed under Lacerations; 43 are open to participants now.

This study's planned enrollment of 30 is below the median of 65 across 128 interventional studies indexed under Lacerations.

Browse Lacerations studies →

Lead sponsor

Edward Via Virginia College of Osteopathic Medicine is the lead sponsor of 24 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 18-45
  • 1st- 4th year medical students, faculty and staff volunteers at specific College of Osteopathic medicine campus

Exclusion criteria

Exclusion Criteria:

  • volunteers who have had ophthalmologic surgery
  • diagnosis of dry eye syndrome
  • diagnosis of temporomandibular joint disease
  • individuals who are greater than 45 years of age.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Population with no history of dry eye

    Pilot that will have participants with no history of dry eye participate to see if there is an increase in tear production

    Procedure: sphenopalatine ganglion release

Interventions

  • Proceduresphenopalatine ganglion release

    Employs the technique of sphenopalatine ganglion release through use of manual manipulation with a gloved finger intraorally

06

What researchers measure

Primary outcomes

  1. Schirmer measurements on Participants

    Will measure tear production via the Schirmer test strips and will compare pre and post intervention

    Time frame: From enrollment to the end of treatment at 1 week

07

Study locations

1 site
  • VCOM- Carolinas Campus
    Spartanburg, South Carolina 29303, United States
08

References and documents

Publications

  • Stevens S. Schirmer's test. Community Eye Health. 2011 Dec;24(76):45. No abstract available. PubMed 22389568 ↗
  • Sherman T, Qureshi Y, Bach A. Osteopathic Manipulative Treatment to Manage Ophthalmic Conditions. J Am Osteopath Assoc. 2017 Sep 1;117(9):568-575. doi: 10.7556/jaoa.2017.111. PubMed 28846123 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Jun 2027, 32 months after the start.

Of 46 non-industry interventional studies with no phase under Lacerations, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 72. This study's planned 32 months is above that.

Counting every sponsor, half of 50 studies reached it within 19 months; a quarter within 12 and three quarters within 72.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2026
First posted
Jun 8, 2026
StartActual
Oct 8, 2024
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Jun 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07632183
Lead sponsor
Edward Via Virginia College of Osteopathic Medicine
Responsible party
Sponsor
First posted
Jun 8, 2026
Start date
Oct 8, 2024
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jun 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion